Excelmab
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A biopharma company developing innovative antibody therapies for cancer and autoimmune diseases.
OncologyImmunology
Technology Platform
A proprietary antibody engineering platform focused on humanization, Fc modification, and bispecific antibody generation to create optimized therapeutic candidates.
Opportunities
Significant market demand in China for novel, locally-developed biologic drugs in oncology and immunology.
Risk Factors
Clinical failure of lead candidates and intense pricing pressure in the Chinese reimbursement environment.
Competitive Landscape
Operates in the highly competitive antibody space, competing with giants like Innovent and Hengrui, as well as global biologics leaders.